Thanks, Don. Let's just start by running through our reported financial results for the second quarter and the first six months of 2017 at a summary level. Second quarter total revenue declined 10% to $25.1 million versus $27.7 million in 2016. Second quarter net loss was $5.5 million or $0.23 per share versus a net loss of $1.4 million or $0.06 per share last year. Second quarter adjusted EBITDA was negative $1.4 million compared to positive $2.5 million a year ago. We define adjusted EBITDA as net income or loss before interest, taxes, depreciation, amortization, stock-based compensation expense and other items that we do not believe are indicative of our core operating performance. Patent enforcement costs had a less significant impact on our net loss and adjusted EBITDA during the second quarter this year than in previous quarters. We incurred $152,000 of patent enforcement cost during the second quarter versus $379,000 in the second quarter last year. For the first half, total revenue declined 21% to $48.1. Net loss was $14.6 million or $0.62 per share in the first half of 2017 versus a net loss of $3.2 million or $0.14 per share last year and adjusted EBITDA for the first half was negative $6.6 million compared to positive $4.5 million last year. For the first half of 2017, patent enforcement costs had a disproportionate impact on both our net loss and adjusted EBTIDA. We incurred $2.9 million of patent enforcement cost during the first half of 2017 versus $573,000 last year. At a summary level, the decline of $11.1 million in first half adjusted EBITDA versus the first half of 2016 was driven by three principle factors. First, a decline in gross profit associated with the year-over-year decline in product revenue and production levels. Second, the increase in patent enforcement costs versus the first half last year and third, increase in operating expenses designed to position Aspen for strong long term growth through investment in sales and marketing personnel and programs and the development of new products, technologies and markets. As we highlighted in the first quarter conference call, our gross profit and gross margin are highly dependent on product revenue and capacity utilization levels. Capacity utilization declined from approximately 98% during the first half of 2016 to 69% this year as a result of both the decline in product revenue and our decision to constrain output levels to manage inventory growth. As a result, gross profit declined sharply during the first half of 2017, in line with our operating plan and our 2017 financial guidance. Importantly, I'd like to reemphasize that we've not seen any significant change to the underlying economics of our business. Our value proposition remains strong and our product pricing, material costs and manufacturing expenses remain relatively stable. The future revenue and volume growth, we'd expect the percentage growth in gross profit and adjusted EBITDA to outpace the associated growth in product revenue. And moving forward, we'd expect to see a meaningful reduction in patent enforcement costs. I'll now provide additional detail on the components of our results. First, I'll discuss revenue. Second quarter total revenue was comprised of product revenue of $24.6 million and research services revenue of $507,000. First half total revenue was comprised of product revenue of $46.9 million and research services revenue of $1.2 million. During the second quarter, product revenue decreased by $2.6 million or 9% versus last year's $27.1 million. As expected, this decline was led by the conclusion of shipments to the multi-year South Asia petrochemical project combined with constrained capital investment, low activity levels in the global energy markets. Revenue decline in our core energy markets was partially offset by growth during the quarter in the LNG and district energy adjacent markets in the United States and project related growth in the Subsea market. During the quarter, shipments decreased 12% to 8.7 million square feet of aerogel blankets, while our average selling price increased by 3% to $2.82 per square foot in line with our prior guidance. This increase in average selling price reflected a year over year increase in the mix of higher priced Subsea products and the impact of price increases enacted in early 2017. For the first half of 2017, product revenue decreased by $12.5 million or 21% versus last year. Again, this decrease was driven by the conclusion of shipments to the multi-year South Asia petrochemical projects and the broad based decline in revenue in the global energy markets. Shipments decreased by 22% to 17 million square feet, while our average selling price increased by 1% versus a year ago to $2.73 per square foot. I'll now turn to our research services revenue. Our research services revenue is related to contract research performed principally for government agencies. Research services revenue decreased by 15% during the second quarter to approximately $500,000, but increased by 5% to $1.2 million during the first half of 2017. This growth was due to the relative value and timing of research contracts versus last year. For the full year, we expect research services revenue of approximately $2.2 million, potentially flat with last year. This expectation is included in our 2017 guidance. Next, I'll discuss gross profit. Gross profit was $3.7 million or 15% of revenue during the second quarter of 2017 versus $6.7 million or 24% last year. This decline in gross profit and gross margin was driven by the 12% decline in shipment volume and a 34% decrease in production volume that we instituted to manage inventory growth, offset in part by decreases in manufacturing, warranty and material costs during the quarter. Gross profit was $5.9 million or 12% of revenue for the first half of 2016 versus $13.2 million or 22% of revenue last year. The decline in first half gross profit and gross margin was principally the 22% percent decline in shipment volume, 30% cumulative reduction in production volume that we enacted to manage inventory growth and a small increase in warranty expense offset in part by reduction in material costs and reduction in manufacturing expenses during the period. Looking forward, we anticipate improvements in gross profit and gross margin principally associated their expectation of increasing revenue, increasing output, and improved capacity utilization levels. Next I'll discuss operating expenses. Second quarter operating expenses grew by $1.1 million or 14% to $9.1 million. This growth in operating expenses was driven by a $600,000 increase in sales and marketing expense, $400,000 increase in research and development expense and $100,000 increase in all other operating expenses during the quarter. The first half of 2017, operating expenses grew by $4.1 million or 25% to $20.4 million. This increase in operating expenses was a result of a $2.3 million increase in pattern enforcement costs year-over-year, $700,000 increase in research and development expense, $600,000 increase for sales personnel and programs, $500,000 year-over-year increase in all other operating expenses. Again, the growth in our second quarter and first half operating expenses reflects our commitment to position Aspen for a solid long-term growth. Next I'll discuss balance sheet and cash flow. Overall, our cash flow was in line with our expectations for the first half of 2017. Cash used in operations of $6 million reflected our negative adjusted EBITDA of $6.6 million offset in part by $600,000 of cash generated by changes in working capital net of interest expense during the period. Capital expenditures during the first half totaled $4.8 million, down from $7.7 million last year. We ended the first half of 2017 with $7 million of cash and minimal debt, current assets of $38 million and shareholders' equity of $103.3 million. In addition, we had $10.5 million available under our revolving credit facility at the end of the second quarter. We're updating our full-year financial outlook for 2017. Total revenue is expected to range between $104 million and $112 million, revised from prior guidance of 102 to 112 million. Net loss is expected to range between $18.2 million and $20.8 million revised from prior guidance of 18.2 to 21.2 million. Adjusted EBITDA is expected to range between a loss of $2 million and a loss of $5 million revised from prior guidance of a loss of $2 million to $4 million. EPS is expected to range between a loss of $0.78 and a loss of $0.89 per share revised from prior guidance of $0.78 to $0.91 per share. This EPS guidance assumes a weighted average of 23.4 million shares outstanding for the year. The 2017 outlook also assumes depreciation and amortization of between $10.6 million and $10.8 million, stock based compensation of between $5 million and $5.2 million and interest expense of $200,000. In addition, this financial outlook includes between $3.9 million and $4.2 million of costs and expenses associated with our patent enforcement actions for the year. We've also increased our projected average selling price for the full year to $2.85 per square foot plus or minus $0.10. This average selling price reflects an increase of $0.10 from our prior guidance due to an expected shift in mix to higher priced products in the second half of the year. For the full year, we continue to expect a gross margin in the mid-teens. This gross margin expectation is unchanged from our prior 2017 outlook. We're reducing our 2017 full-year capital expenditure guidance by $1 million to $6.3 million. The $6.3 million projection is comprised of $1 million, new projects to be initiated during the year and $5.3 million in final expenditures for the pilot line, equipment and support of new products and other projects approved and initiated during 2016. Capital expenditures during the first half to 2017 totaled $4.8 million. Accordingly, our 2017 outlook reflects our expectation that capital spending will be approximately $1.5 million during the second half of the year. Turning to cash at an aggregate level, we expect to generate cash during the second half of the year due to projected improvements in operating performance, anticipated declines in pattern enforcement costs, planned reduction in inventory balances, reductions in capital spending during the period. Within the context of the range of our 2017 full-year outlook, we continue to expect to exit the year with between $10 million and $14 million of cash on hand. As always, project work and product mix can create quarterly variability and we'll update our annual outlook at the time of each earnings release during 2017 or as otherwise necessary. I'll now turn the call back to Emily for question and answer.